骨质疏松症治疗药物的分类与用药选择

Classification and selection of drugs for treating osteoporosis

骨质疏松症是影响老年骨骼健康的主要疾病,其致残率和致死率高,严重影响着患者的生活质量和寿命,并给家庭和社会带来巨大人力和经济负担。随着人口老龄化进程的加剧,骨质疏松症越来越为社会所关注,抗骨质疏松药物研究已成为热点。传统的分类方法是按药物作用机制进行分类,种类繁多的药物使临床用药选择困难。治疗过程中应该既要考虑药物作用机制又要考虑患者个体机能,本着方便选择用药的原则进行了重新分类。

Osteoporosis is the main disease affecting the health of the elderly.Its disability and mortality are high,which seriously affects the quality of life and life of patients,and brings huge human and economic burden to families and society.With the intensification of the population aging process,osteoporosis has become more and more concerned by the society,and anti-osteoporosis drug research has become a hot spot.Traditional classification methods are classified according to the mechanism of action of drugs,and a wide variety of drugs make clinical drug selection difficult.In the course of treatment,both the mechanism of action of the drug and the individual function of the patient should be considered,and the principle of drug selection should be reclassified.